logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Centre François Baclesse

+33231455050
dons@baclesse.unicancer.fr
Source: Site record.
http://www.baclesse.fr

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

The Centre François Baclesse, located at 3 Av. du Général Harris in Caen, France, is a premier, non-profit cancer research and treatment facility. Operating as one of France’s 18 regional cancer centers within the Unicancer network, it manages a threefold public service mission dedicated to specialized oncology care, research, and medical education. Renowned internationally, it ranks among the world’s top specialized oncology hospitals and is uniquely certified with the highest "Level A" rating by the French National Authority for Health (HAS). The center features a high-tech platform utilizing cutting-edge therapeutic innovations, such as being one of only three French facilities offering specialized proton therapy, and it strictly applies conventional public healthcare rates with no private sector fees.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Specialized hospital

Business Subcategory

Source: Human-provided. Specialized hospital
Source: Human-provided. Cancer treatment center
Source: Trial-derived.
66Total Trials
Source: Trial-derived.
12Recruiting Trials
Source: Trial-derived.
28Active Trials
Source: Trial-derived.
29Completed Trials
Source: Trial-derived.
104Unique Conditions
Source: Trial-derived.
68Unique Sponsors

Conditions

Source: Trial-derived. Ovarian Cancer (5)Source: Trial-derived. Breast Cancer (4)Source: Trial-derived. Carcinoma, Non-Small-Cell Lung (2)Source: Trial-derived. Colorectal Cancer (2)Source: Trial-derived. Fallopian Tube Cancer (2)Source: Trial-derived. Gastroesophageal Junction Adenocarcinoma (2)Source: Trial-derived. Lung Cancer (2)Source: Trial-derived. Metastatic Colorectal Cancer (2)

Sponsors

Source: Trial-derived. Hoffmann-La Roche (6)Source: Trial-derived. Intergroupe Francophone de Cancerologie Thoracique (6)Source: Trial-derived. EMD Serono Research & Development Institute, Inc. (5)Source: Trial-derived. Merck Sharp & Dohme LLC (5)Source: Trial-derived. Centre Francois Baclesse (4)Source: Trial-derived. Boehringer Ingelheim (3)Source: Trial-derived. Center Eugene Marquis (3)Source: Trial-derived. Federation Francophone de Cancerologie Digestive (3)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. 12-lead ECG
Source: AI-inferred. CT Scan
Source: AI-inferred. MRI
Source: AI-inferred. PET-CT

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. Flow Cytometry
Source: AI-inferred. Sequencing / genomics

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Tumour tissue biopsy (guidance not stated)
Source: AI-inferred. Intensity-modulated radiation therapy
Source: AI-inferred. Radiopharmaceutical handling and administration

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom
Source: Google. Wheelchair accessible seating

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Circulating tumour cell enumeration
Source: AI-inferred. Left ventricular ejection fraction assessment
Source: AI-inferred. Mismatch repair (MMR) status testing
Source: AI-inferred. PIK3CA mutation testing of tumour tissue